Research Article
INVESTIGATION OF ANTIOXIDANT OF NOVEL 4-[2-(2-THIENYLCARBONYLOXY)-3-METHOXYBENZYLIDENEAMINO]-4,5-DIHYDRO1H-1,2,4-TRIAZOL-5-ONE DERIVATIVES
FORMULATION, DEVELOPMENT AND OPTIMIZATION OF ALPRAZOLAM 0.5 MG SUSTAINED RELEASE TABLET WITH 12 HOURS RELEASE PROFILE
METHOD DEVELOPMENT AND ITS VALIDATION FOR SIMULTANEOUS ESTIMATION OF NEVIRAPINE & LAMIVUDINE BY RP-HPLC IN COMBINATION TABLET DOSAGE FORM
ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF PIPERAQUINE TETRAPHOSPHATE AND DIHYDROARTEMISININ IN COMBINE DOSAGE FORMS